Personalized medicine: An update of salivary biomarkers for periodontal diseases

Periodontology 2000

Volumn 70, Issue 1, 2016, Pages 26-37

  Korte, Dina L ^a   Kinney, Janet ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BLOOD; CHEMISTRY; HUMAN; METABOLISM; PERIODONTAL DISEASES; PERSONALIZED MEDICINE; PROCEDURES; SALIVA;

BIOMARKERS; HUMANS; PERIODONTAL DISEASES; PRECISION MEDICINE; SALIVA;

EID: 84949643818     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12103     Document Type: Review

References (87)

1. Albandar JM. Underestimation of periodontitis in NHANES surveys. J Periodontol 2011: 82: 337-341.
2. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol 1999: 70: 13-29.
3. Alexander MB, Damoulis PD. The role of cytokines in the pathogenesis of periodontal disease. Curr Opin Periodontol 1994: 2: 39-53.
4. Al-Sabbagh M, Alladah A, Lin Y, Kryscio RJ, Thomas MV, Ebersole JL, Miller CS. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. J Periodontal Res 2012: 47: 389-395.
5. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999: 4: 1-6.
6. Armitage GC. The complete periodontal examination. Periodontol 2000 2004: 34: 22-33.
7. Armitage GC. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000 2010: 53: 70-88.
8. Baelum V, Lopez R. Defining a periodontitis case: analysis of a never-treated adult population. J Clin Periodontol 2012: 39: 10-19.
9. Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 2007: 149: 217-225.
10. Bassim CW, Redman RS, DeNucci DJ, Becker KL, Nylen ES. Salivary procalcitonin and periodontitis in diabetes. J Dent Res 2008: 87: 630-634.
11. Becerik S, Ozsan N, Gürkan A, Oztürk VÖ, Atilla G, Emingil G. Toll-like receptor 4 and membrane-bound CD14 expressions in gingivitis, periodontitis and CsA-induced gingival overgrowth. Arch Oral Biol 2011: 15: 797-819.
12. Brinkmann O, Zhang L, Giannobile WV, Wong DT. Salivary Biomarkers for periodontal disease diagnostics. Expert Opin Med Diagn 2011: 5: 25-35.
13. Burlage FR, Pijpe J, Coppes RP, Hemels ME, Meertens H, Canrinus A, Vissink A. Variability of flow rate when collecting stimulated human parotid saliva. Eur J Oral Sci 2005: 113: 386-390.
14. Cappellen D, Luong-Nguyen N-H, Bongiovanni S, Grenet O, Wanke C, Mira Susa M. Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκB. J Biol Chem 2002: 277: 21971-21982.
15. Chambers DA, Crawford JM, Mukherjee S, Cohen RL. Aspartate aminotransferase increases in crevicular fluid during experimental periodontitis in beagle dogs. J Periodontol 1984: 55: 526-530.
16. Chaudhari AU, Byakod GN, Waghmare PF, Karhadkar VM. Correlation of levels of interleukin-1β in gingival crevicular fluid to the clinical parameters of chronic periodontitis. J Contemp Dent Pract 2011: 12: 52-59.
17. Christodoulides N, Floriano PN, Sanchez X, Li L, Sc B, Hocquard K, Patton A, Muldoon R, Miller CS, Ebersole JL, Redding S, Yeh C, Furmaga WB, Wampler DA, Bozkurt B, Ballantyne CM, McDevitt JT. Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. Methodist Debakey Cardiovasc J 2012: 8: 6-12.
18. Costa PP, Trevisan GL, Macedo GO, Palioto DB, Souza SL, Grisi MF, Novaes AB Jr, Taba M Jr. Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol 2010: 81: 384-391.
19. Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 2010: 8: 481-490.
20. Dehiya P, Kamal R, Gupta R, Bhardwaj R, Chaudhary K, Kaur S. Reactive oxygen species in periodontitis. J Indian Soc Periodontol 2013: 17: 411-416.
21. Delima AJ, Van Dyke TE. Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 2003: 31: 55-76.
22. Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, Bassilian S, Bedi GS, Boontheung P, Cociorva D, Delahunty CM, Denny T, Dunsmore J, Faull KF, Gilligan J, Gonzalez-Begne M, Halgand F, Hall SC, Han X, Henson B, Hewel J, Hu S, Jeffrey S, Jiang J, Loo JA, Ogorzalek Loo RR, Malamud D, Melvin JE, Miroshnychenko O, Navazesh M, Niles R, Park SK, Prakobphol A, Ramachandran P, Richert M, Robinson S, Sondej M, Souda P, Sullivan MA, Takashima J, Than S, Wang J, Whitelegge JP, Witkowska HE, Wolinsky L, Xie Y, Xu T, Yu W, Ytterberg J, Wong DT, Yates JR 3rd, Fisher SJ. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008: 7: 1994-2006.
23. Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res 2012: 91: 914-920.
24. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-1beta profiles in periodontal disease. J Clin Periodontol 2002: 29: 48-53.
25. Fine DH, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C, McKiernan M, Donnelly R, Gunsolley J. Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease? J Periodontol 2009: 80: 106-113.
26. Geivelis M, Turner DW, Pederson ED, Lamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993: 64: 980-983.
27. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013: 62: 59-94.
28. Giannobile WV. Salivary diagnostics for periodontal diseases. J Am Dent Assoc 2012: 143(10 suppl): 6-11.
29. Giannobile WV, Braun TM, Caplis AK, Doucette-Stamm L, Duff GW, Kornman KS. Patient stratification for preventive care in dentistry. J Dent Res 2013: 92: 694-701.
30. Giannobile WV, Kornman KS, Williams RC. Personalized medicine enters dentistry: what might this mean for clinical practice? J Am Dent Assoc 2013: 144: 874-876.
31. Goodson JM. Diagnosis of periodontitis by physical measurement: interpretation from episodic disease hypothesis. J Periodontol 1992: 63: 373-382.
32. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003: 74: 391-401.
33. Gursoy UK, Könönen E, Pradhan-Palikhe P, Tervahartiala T, Pussinen PJ, Suominen-Taipale L, Sorsa T. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010: 37: 487-493.
34. Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, Uitto V, Paju S, Sorsa T. Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers 2011: 30: 299-305.
35. Imrey PB, Chilton NW. Design and analytic concepts for periodontal clinical trials. J Periodontol 1992: 63: 1124-1140.
36. Jin Q, Cirelli JA, Park CH, Sugai JV, Taba M Jr, Kostenuik PJ, Giannobile WV. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007: 78: 1300-1308.
37. Kariyawasam AP, Dawes C. A circannual rhythm in unstimulated salivary flow rate when the ambient temperature varies by only about 2 degrees C. Arch Oral Biol 2005: 50: 919-922.
38. Kavanagh DA, O'Mullane DM, Smeeton N. Variation of salivary flow rate in adolescents. Arch Oral Biol 1998: 43: 347-352.
39. Kinney JS, Morelli T, Braun T, Ramseier CA, Herr AE, Sugai JV, Shelburne CE, Rayburn LA, Singh AK, Giannobile WV. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res 2011: 90: 752-758.
40. Kornman KS, Duff GW. Personalized medicine: will dentistry ride the wave or watch from the beach? J Dent Res 2012: 91(S8): 7-11.
41. Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004: 15: 49-60.
42. Lang NP, Tonetti MS. Periodontal diagnosis in treated periodontitis. Why, when and how to use clinical parameters. J Clin Periodontol 1996: 23: 240-250.
43. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants 2006: 21: 543-550.
44. Loo JA, Yan W, Ramachandran P, Wong DT. Comparative human salivary and plasma proteomes. J Dent Res 2010: 89: 1016-1023.
45. Louridis O, Demetriou N, Bazopoulou-Kyrkanides E. Environmental temperature effect on the secretion rate of "resting" and stimulated human mixed saliva. J Dent Res 1970: 49: 1136-1140.
46. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, Floriano PN, Simmons G, Bhagwandin B, Jacobson JW, Redding SW, Ebersole JL, McDevitt JT. Current developments in salivary diagnostics. Biomark Med 2010: 4: 171-189.
47. Miller CS, King CP, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006: 137: 322-329.
48. Ng PYB, Donley M, Hausmann E, Hutson AD, Rossomando EF, Scannapieco F. Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol 2007: 49: 252-260.
49. Nibali L, Fedele S, D'Aiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral Dis 2012: 18: 236-243.
50. Nomura Y, Shimada Y, Hanada N, Numabe Y, Kamoi K, Sato T, Gomi K, Arai T, Inagaki K, Fukuda M, Noguchi T, Yoshie H. Salivary biomarkers for predicting the progression of chronic periodontitis. Arch Oral Biol 2012: 57: 413-420.
51. Nomura Y, Tamaki Y, Tanaka T, Arakawa H, Tsurumoto A, Kirimura K, Sato T, Hanada N, Kamoi K. Screening of periodontitis with salivary enzyme tests. J Oral Sci 2006: 48: 177-183.
52. Page RC. Host response tests for diagnosing periodontal diseases. J Periodontol 1992: 63(4 Suppl): 356-366.
53. Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997: 14: 9-11.
54. Pant Pai N, Balram B, Shivkumar S, Martinez-Cajas JL, Claessens C, Lambert G, Peeling RW, Joseph L. Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. Lancet 2012: 12: 373-380.
55. Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem 2011: 57: 675-687.
56. Pihlstrom BL. Periodontal risk assessment, diagnosis and treatment planing. Periodontol 2000 2001: 25: 37-58.
57. Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, Rayburn LA, Tran HM, Singh AK, Giannobile WV. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009: 80: 436-446.
58. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005: 32(Suppl 6): 108-129.
59. Schenkels LC, Veerman EC, Nieuw Amerongen AV. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med 1995: 6: 161-175.
60. Schierano G, Bellone G, Cassarino E, Pagano M, Preti G, Emanuelli G. Transforming growth factor-beta and interleukin 10 in oral implant sites in humans. J Dent Res 2003: 82: 428-432.
61. Sexton WM, Lin Y, Kryscio RJ, Dawson DR, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 2011: 38: 434-441.
62. Shannon IL, Chauncey HH. A parotid fluid collection device with improved stability characteristics. J Oral Ther Pharmacol 1967: 4: 93-97.
63. Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol 2010: 81: 1118-1123.
64. Ship JA. Improving oral health in older people. J Am Geriatr Soc 2002: 50: 1454-1455.
65. Ship JA, Beck JD. Ten-year longitudinal study of periodontal attachment loss in healthy adults. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 281-290.
66. Ship JA, Pillemer SR, Baum BJ. Xerostomia and the geriatric patient. J Am Geriatr Soc 2002: 50: 535-543.
67. Sima C, Glogauer M. Diabetes mellitus and periodontal diseases. Curr Diab Rep 2013: 13: 445-452.
68. Slaughter YA, Malamud D. Oral diagnostics for the geriatric populations: current status and future prospects. Dent Clin North Am 2005: 49: 445-461.
69. Slavkin HC. Toward molecularly based diagnostics for the oral cavity. J Am Dent Assoc 1998: 129: 1138-1143.
70. Slavkin HC. Revising the scope of practice for oral health professionals: enter genomics. J Am Dent Assoc 2014: 145: 228-230.
71. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 1992: 63(4 Suppl): 322-331.
72. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM, Brown DL, Mantyla P. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006: 38: 306-321.
73. Souza PP, Lerner UH. The role of cytokines in inflammatory bone loss. Immunol Invest 2013: 42: 555-622.
74. Spielmann N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral Dis 2011: 17: 345-354.
75. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987: 138: 1464-1468.
76. Taba M, Kinney J, Kim AS, Giannobile WV. Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am 2005: 49: 551-571.
77. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997: 15: 797-819.
78. Todorovic T, Dozic I, Vicente-Barrero M, Ljuskovic B, Pejovic J, Marjanovic M, Knezevic M. Salivary enzymes and periodontal disease. Med Oral Patol Oral Cir Bucal 2006: 11: E115-E119.
79. Totan A, Greabu M, Totan C, Spinu T. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases? Clin Chem Lab Med 2006: 44: 662-665.
80. Veerman EC, Van den Keybus PA, Vissink A, Nieuw Amerongen AV. Human glandular salivas: their separate collection and analysis. Eur J Oral Sci 1996: 104: 346-352.
81. Vissink A, Spijkervet FKL, Van Nieuw Amerongen A. Aging and saliva: a review of the literature. Spec Care Dentist 1996: 16: 95-103.
82. Wu AJ, Baum BJ, Ship JA. Extended stimulated parotid and submandibular secretion in a healthy young and old population. J Gerontol 1995: 50A: M45-M48.
83. Yan W, Apweiler R, Balgley BM, Boontheung P, Bundy JL, Cargile BJ, Cole S, Fang X, Golzalez-Begne M, Griffin TJ, Hagen F, Hu S, Wolinsky LE, Lee CS, Malumud D, Melvin JE, Menon R, Mueller M, Qiao R, Rhodus NL, Sevinsky JR, States D, Stephenson JL, Than S, Yates JR, Yu W, Xie H, Xie Y, Omenn GS, Loo JA, Wong DT. Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl 2009: 3: 116-134.
84. Yucel-Lindberg T, Båge T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med 2013: 15: e7.
85. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park N et al. Salivary Transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010: 138: 949-957.
86. Zhang L, Henson BS, Camargo PM, Wong DT. The clinical value of salivary biomarkers for periodontal disease. Periodontol 2000 2009: 51: 25-37.
87. Zimmermann BG, Park NJ, Wong DT. Genomic targets in saliva. Ann N Y Acad Sci 2007: 1098: 184-191.